Enhancing Cognition in the Intellectually Intact: Possibilities and Pitfalls,

Authors

Peter J. Whitehouse
Eric Juengst
Maxwell Mehlman, Case Western University School of LawFollow
Thomas H. Murray

Abstract

As science learns more about how the brain works, and fails to work, the possibility for developing “cognition enhancers” becomes more plausible. And the demand for drugs that can help us think faster, remember more, and focus more keenly has already been demonstrated by the market success of drugs like Ritalin, which tames the attention span, and Prozac, which ups the competitive edge. The new drug Aricept, which improves memory, most likely will join them. Whether such drugs are good for individuals, or for society, is an open question, one that demands far more public discussion.

Keywords

Cognition Enhancers

Publication Date

1997

Document Type

Article

Place of Original Publication

Hastings Center Report

Publication Information

27 (3) Hastings Center Report 14(May-June 1997)

Repository Citation

Whitehouse, Peter J.; Juengst, Eric; Mehlman, Maxwell; and Murray, Thomas H., "Enhancing Cognition in the Intellectually Intact: Possibilities and Pitfalls," (1997). Faculty Publications. 642.
https://scholarlycommons.law.case.edu/faculty_publications/642